Literature DB >> 16694859

THE RELATIVE CHANGES IN AFFERENT AND EFFERENT ARTERIOLAR RESISTANCE IN THE NORMAL HUMAN KIDNEY.

H Lamport1.   

Abstract

Entities:  

Year:  1941        PMID: 16694859      PMCID: PMC435084          DOI: 10.1172/JCI101247

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  RELATIONS OF EFFECTIVE RENAL BLOOD FLOW AND GLOMERULAR FILTRATION TO TUBULAR EXCRETORY MASS IN NORMAL MAN.

Authors:  W Goldring; H Chasis; H A Ranges; H W Smith
Journal:  J Clin Invest       Date:  1940-09       Impact factor: 14.808

2.  GLOMERULAR DYNAMICS IN THE NORMAL HUMAN KIDNEY.

Authors:  H W Smith; H Chasis; W Goldring; H A Ranges
Journal:  J Clin Invest       Date:  1940-09       Impact factor: 14.808

3.  FORMULAE FOR AFFERENT AND EFFERENT ARTERIOLAR RESISTANCE IN THE HUMAN KIDNEY: AN APPLICATION TO THE EFFECTS OF SPINAL ANESTHESIA.

Authors:  H Lamport
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

  3 in total
  4 in total

1.  IMPROVEMENTS IN CALCULATION OF RENAL RESISTANCE TO BLOOD FLOW. CHARTS FOR OSMOTIC PRESSURE AND VISCOSITY OF BLOOD.

Authors:  H Lamport
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

2.  FORMULAE FOR AFFERENT AND EFFERENT ARTERIOLAR RESISTANCE IN THE HUMAN KIDNEY: AN APPLICATION TO THE EFFECTS OF SPINAL ANESTHESIA.

Authors:  H Lamport
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

3.  Evaluation of renal resistances, with special reference to changes in essential hypertension.

Authors:  D M GOMEZ
Journal:  J Clin Invest       Date:  1951-10       Impact factor: 14.808

4.  Studies in renal circulation during periods of life stress and accompanying emotional reactions in subjects with and without essential hypertension; observations on the role of neural activity in regulation of renal blood flow.

Authors:  J B PFEIFFER; H G WOLFF; O S WINTER
Journal:  J Clin Invest       Date:  1950-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.